Volume 15 - summer                   RJMS 2008, 15 - summer: 73-80 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Zaker, F, Mohammadzadeh, M, Aghaeepoor, M, Rastegar Lari, G. Study of Mutations in c-kit Exons 8&17 in Iranian Patients with Acute Myeloid Leukemia. RJMS 2008; 15 :73-80
URL: http://rjms.iums.ac.ir/article-1-1007-en.html
Abstract:   (10449 Views)

 

  Background & Aim: Mutations in c-kit gene cause autonomously proliferation of leukemic cells with an unfavorable prognosis.These mutations including exon 8 deletion and insertion in the fifth extracellular Ig-like domain and exon 17 point mutation in tyrosine kinase domain of c-kit receptors are important in acute myeloid leukemia. The aim of this study was to set up molecular diagnosis and screening of these mutations in AML patients.

  Patients and Method: This observational descriptive study of mutations in c-kit receptors was done on 212 patients with AML . Exon 8 mutations were analyzed by PCR method with specific primers.Then, PCR products were run in 10% CSGE and the results were documented. We also studied exon 17 point mutations with RFLP technique and using AatII enzyme on PCR products of these patients.

  Results: Exon 8 mutations were seen in 1.4% of AML patients though, the results were different in different subtypes. Also, 4.7% of the patients showed D816 (exon 17) mutations with different findings in the subtypes of AML .

  Conclusion: This study revealed that c-kit mutations constitute a significant percentage of AML (M2&M4 subtypes) cases in Iran. Thus, molecular diagnosis of these mutations could help to select a better treatment.

Full-Text [PDF 346 kb]   (2972 Downloads)    
Type of Study: Research | Subject: hematology

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC-SA 4.0 | Razi Journal of Medical Sciences

Designed & Developed by : Yektaweb